Michael Gold

Pathfinder International — United States

Medicine · Health Sciences

54h-index10.2kcitations267works4.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Food Allergy and Anaphylaxis Research(50), Vaccine Coverage and Hesitancy(39), Dementia and Cognitive Impairment Research(28), Alzheimer's disease research and treatments(27), Influenza Virus Research Studies(25)

Publications267 total

The Relationship Between Participant Pretreatment Clinical Presentation and the Quality of Psilocybin Experience
Journal of Clinical Psychopharmacology·2025
Randomized, Double‐Blind, Placebo‐Controlled, Multiple‐Dose Studies to Assess the Safety and Efficacy of Elezanumab when Added to Standard of Care in Relapsing and Progressive Forms of Multiple Sclerosis
Annals of Neurology·2025· 1 citedOpen Access
Axillary Hyperhidrosis HDSM-Ax-7 Patient-Reported Outcomes for Sofpironium Topical Gel,12.45%: A Multicenter, Randomized, Controlled Double-Blind Study (NCT03836287)
SKIN The Journal of Cutaneous Medicine·2025Open Access
Navacaprant, a Novel and Highly Selective Kappa Opioid Receptor Antagonist, in Adults With Major Depressive Disorder
Journal of Clinical Psychopharmacology·2025· 4 citedOpen Access
An oligodendrocyte silencer element underlies the pathogenic impact of lamin B1 structural variants
Nature Communications·2025· 4 citedOpen Access
Key considerations for combination therapy in Alzheimer's clinical trials: Perspectives from an expert advisory board convened by the Alzheimer's drug discovery foundation
The Journal of Prevention of Alzheimer s Disease·2025· 12 citedOpen Access
Allergen‐Specific <scp>IgE</scp> is a Stronger Predictor of Remission Following Peanut Oral Immunotherapy Than Age in Children Aged 1–10 Years
Allergy·2024· 5 citedOpen Access
Allergen specific IgE is a stronger predictor of remission following Peanut Oral Immunotherapy than age in children aged 1-10 years
2024· 1 citedOpen Access
Two‐year post‐treatment outcomes following peanut oral immunotherapy in the Probiotic and Peanut Oral Immunotherapy‐003 Long‐Term (<scp>PPOIT</scp>‐<scp>003LT</scp>) study
Allergy·2024· 11 citedOpen Access
Why should academia care about the Target Product Profile?
Journal of Translational Medicine·2024· 4 citedOpen Access
Facilitating the use of the target product profile in academic research: a systematic review
Journal of Translational Medicine·2024· 11 citedOpen Access
Forensic Approach to Death as an Adverse Event Following Immunization
Encyclopedia of Forensic and Legal Medicine·2024
Navacaprant, a Novel Kappa Opioid Receptor Antagonist for Major Depressive Disorder: A Randomized Placebo-Controlled Phase 2 Trial
Biological Psychiatry·2024· 2 cited
Interaction Between Baseline Participant Factors and Treatment Effects Following Peanut Oral Immunotherapy
The Journal of Allergy and Clinical Immunology In Practice·2023· 9 cited
Facilitating the use of the target product profile in academic research
Alzheimer s & Dementia·2023Open Access
Vaccines, medications and food allergy
Elsevier eBooks·2023
Scoping Literature Review Study of Short Message Services (SMS) and Mobile App-Based Technology as an mHealth tool for Active Participant Centered (MAPC) Adverse Events Following Immunisations (AEFIs) Surveillance using a Low Middle-Income Country (LMIC) lens
Journal of Clinical Cases & Reports·2023Open Access
The clinicopathological features of thrombosis with thrombocytopenia syndrome following ChAdOx1-S (AZD1222) vaccination and case outcomes in Australia: a population-based study
The Lancet Regional Health - Western Pacific·2023· 6 citedOpen Access
An oligodendrocyte silencer element underlies the pathogenic impact of lamin B1 structural variants
2023· 2 citedOpen Access
Association of Reaction Symptoms and Eliciting Dose With Health-Related Quality of Life in Children With Peanut Allergy
The Journal of Allergy and Clinical Immunology In Practice·2023
page 1 of 14Next →

Frequent Co-authors

Maria Makrides(8), Adam L. Boxer(8), Debra J. Palmer(7), Irene Litvan(7), Bruce L. Miller(6), Günter U. Höglinger(5), Kenneth M. Heilman(4), Susan L. Prescott(4), Lawrence I. Golbe(4), Jean‐Christophe Corvol(4), Albert Ludolph(4), Stefan Lorenzl(4), Erik D. Roberson(4), Clifford R. Jack(4), Christopher Randolph(4), Iryna Lobach(4), Joe Hirman(4), Bruce H. Morimoto(4), Thomas Sullivan(4), Danny Camfferman(4)